{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:52:36Z","timestamp":1778158356595,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T00:00:00Z","timestamp":1625875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T00:00:00Z","timestamp":1625875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1245\/s10434-021-10441-z","type":"journal-article","created":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T20:02:45Z","timestamp":1625947365000},"page":"5568-5579","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["A National Survey of Breast Surgeons and Radiation Oncologists on Contemporary Axillary Management in Mastectomy Patients"],"prefix":"10.1245","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4750-5028","authenticated-orcid":false,"given":"Chandler S.","family":"Cortina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Bergom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgan Ashley","family":"Craft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"British","family":"Fields","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruta","family":"Brazauskas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Currey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda L.","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,10]]},"reference":[{"key":"10441_CR1","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/00000658-189407000-00075","volume":"20","author":"W Halsted","year":"1894","unstructured":"Halsted W. The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June 1889, to January 1894. Ann Surg. 1894;20:497\u2013555.","journal-title":"Ann Surg."},{"issue":"4","key":"10441_CR2","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.amjsurg.2019.07.013","volume":"218","author":"LH Rosenberger","year":"2019","unstructured":"Rosenberger LH, Thomas SM, Plichta JK, et al. Decreasing rates of axillary lymph node dissections over time: implications for surgical resident exposure and operative skills development. Am J Surg. 2019;218(4):786\u201391. https:\/\/doi.org\/10.1016\/j.amjsurg.2019.07.013.","journal-title":"Am J Surg."},{"key":"10441_CR3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/00000658-199409000-00015","volume":"220","author":"AE Giuliano","year":"1994","unstructured":"Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220:391\u20138.","journal-title":"Ann Surg."},{"issue":"10","key":"10441_CR4","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","volume":"11","author":"DN Krag","year":"2010","unstructured":"Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11(10):927\u201333. https:\/\/doi.org\/10.1016\/S1470-2045(10)70207-2.","journal-title":"Lancet Oncol."},{"issue":"13","key":"10441_CR5","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1200\/JCO.2000.18.13.2553","volume":"18","author":"AE Giuliano","year":"2000","unstructured":"Giuliano AE, Haigh PI, Brennan MB, et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol. 2000;18(13):2553\u20139.","journal-title":"J Clin Oncol."},{"issue":"6","key":"10441_CR6","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/jama.2011.90","volume":"305","author":"AE Giuliano","year":"2011","unstructured":"Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305(6):569\u201375. https:\/\/doi.org\/10.1001\/jama.2011.90.","journal-title":"JAMA."},{"issue":"10","key":"10441_CR7","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2017.11470","volume":"318","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Ballman KV, McCall L, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA. 2017;318(10):918\u201326. https:\/\/doi.org\/10.1001\/jama.2017.11470.","journal-title":"JAMA."},{"issue":"12","key":"10441_CR8","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","volume":"15","author":"M Donker","year":"2014","unstructured":"Donker M, van Tienhoven G, Straver ME, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981\u201322023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15(12):1303\u201310. https:\/\/doi.org\/10.1016\/S1470-2045(14)70460-7.","journal-title":"Lancet Oncol."},{"issue":"10","key":"10441_CR9","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/S1470-2045(18)30380-2","volume":"19","author":"V Galimberti","year":"2018","unstructured":"Galimberti V, Cole BF, Viale G, et al. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23\u201301): 10-year follow-up of a randomised, controlled phase 3 trial. Lancet Oncol. 2018;19(10):1385\u201393. https:\/\/doi.org\/10.1016\/S1470-2045(18)30380-2.","journal-title":"Lancet Oncol."},{"issue":"1","key":"10441_CR10","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1245\/s10434-012-2569-y","volume":"20","author":"M Sol\u00e1","year":"2013","unstructured":"Sol\u00e1 M, Alberro JA, Fraile M, et al. Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048\/13\/2000. Ann Surg Oncol. 2013;20(1):120\u20137. https:\/\/doi.org\/10.1245\/s10434-012-2569-y.","journal-title":"Ann Surg Oncol."},{"key":"10441_CR11","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.ejso.2016.12.011","volume":"43","author":"A Savolt","year":"2017","unstructured":"Savolt A, Peley G, Polgar C, et al. Eight-year follow up result of the OTOASOR trial: the optimal treatment of the axilla: surgery or radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: a randomized, single-centre, phase III, noninferiority trial. Eur J Surg Oncol. 2017;43:672\u20139.","journal-title":"Eur J Surg Oncol."},{"issue":"4","key":"10441_CR12","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1056\/NEJMoa1415340","volume":"373","author":"TJ Whelan","year":"2015","unstructured":"Whelan TJ, Olivotto IA, Parulekar WR, et al. Regional nodal irradiation in early-stage Breast Cancer. N Engl J Med. 2015;373(4):307\u201316. https:\/\/doi.org\/10.1056\/NEJMoa1415340.","journal-title":"N Engl J Med."},{"issue":"29","key":"10441_CR13","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1200\/JCO.20.00459","volume":"38","author":"GE Naoum","year":"2020","unstructured":"Naoum GE, Roberts S, Brunelle CL, et al. Quantifying the impact of axillary surgery and nodal irradiation on breast cancer-related lymphedema and local tumor control: long-term results from a prospective screening trial. J Clin Oncol. 2020;38(29):3430\u20138. https:\/\/doi.org\/10.1200\/JCO.20.00459.","journal-title":"J Clin Oncol."},{"key":"10441_CR14","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/01.sla.0000245472.47748.ec","volume":"245","author":"I Langer","year":"2007","unstructured":"Langer I, Guller U, Berclaz G, et al. Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients. Ann Surg. 2007;245:452\u201361.","journal-title":"Ann Surg."},{"key":"10441_CR15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10549-005-9025-7","volume":"95","author":"A Fleissig","year":"2006","unstructured":"Fleissig A, Fallowfield LJ, Langridge CI, et al. Postoperative arm morbidity and quality of life: results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat. 2006;95:279\u201393.","journal-title":"Breast Cancer Res Treat."},{"issue":"1","key":"10441_CR16","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/SLA.0000000000003491","volume":"274","author":"HK Byun","year":"2021","unstructured":"Byun HK, Chang JS, Im SH, et al. Risk of lymphedema following contemporary treatment for breast cancer: an analysis of 7617 consecutive patients from a multidisciplinary perspective. Ann Surg. 2021;274(1):170\u20138. https:\/\/doi.org\/10.1097\/SLA.0000000000003491.","journal-title":"Ann Surg."},{"issue":"11","key":"10441_CR17","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1001\/jamaoncol.2018.1908","volume":"4","author":"M Morrow","year":"2018","unstructured":"Morrow M, Jagsi R, McLeod MC, Shumway D, Katz SJ. Surgeon attitudes toward the omission of axillary dissection in early breast cancer. JAMA Oncol. 2018;4(11):1511\u20136. https:\/\/doi.org\/10.1001\/jamaoncol.2018.1908.","journal-title":"JAMA Oncol."},{"issue":"2","key":"10441_CR18","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.suc.2012.12.007","volume":"93","author":"DM Black","year":"2013","unstructured":"Black DM, Mittendorf EA. Landmark trials affecting the surgical management of invasive breast cancer. Surg Clin North Am. 2013;93(2):501\u201318. https:\/\/doi.org\/10.1016\/j.suc.2012.12.007.","journal-title":"Surg Clin North Am."},{"issue":"3","key":"10441_CR19","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1245\/s10434-019-08154-5","volume":"27","author":"CS Fisher","year":"2020","unstructured":"Fisher CS, Margenthaler JA, Hunt KK, Schwartz T. The landmark series: axillary management in breast cancer. Ann Surg Oncol. 2020;27(3):724\u20139. https:\/\/doi.org\/10.1245\/s10434-019-08154-5.","journal-title":"Ann Surg Oncol."},{"key":"10441_CR20","unstructured":"NCCN Clinical Practice Guidelines in Oncology 2021. Updated March 12, 2021. Version 2.2021. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf. Accessed 15 Mar 2021."},{"key":"10441_CR21","unstructured":"Consensus Guideline on the Management of the Axilla in Patients With Invasive\/In-Situ Breast Cancer. The American Society of Breast Surgeons Official Statement. Published 24 Sep 2019. https:\/\/www.breastsurgeons.org\/docs\/statements\/Consensus-Guideline-on-the-Management-of-the-Axilla.pdf?v2. Accessed 4 May 2021."},{"issue":"1","key":"10441_CR22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1245\/s10434-016-5558-8","volume":"24","author":"A Recht","year":"2017","unstructured":"Recht A, Comen EA, Fine RE, et al. Postmastectomy radiotherapy: an american society of clinical oncology, american society for radiation oncology, and society of surgical oncology focused guideline update. Ann Surg Oncol. 2017;24(1):38\u201351. https:\/\/doi.org\/10.1245\/s10434-016-5558-8.","journal-title":"Ann Surg Oncol."},{"key":"10441_CR23","unstructured":"Breast Cancer Treatment (Adult) (PDQ\u00ae)\u2013Health Professional Version. NIH National Cancer Institute. Updated 18 Mar 2021. https:\/\/www.cancer.gov\/types\/breast\/hp\/breast-treatment-pdq?redirect=true#_1021_toc. Accessed 4 May 2021"},{"issue":"5","key":"10441_CR24","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1200\/JCO.2016.71.0947","volume":"35","author":"GH Lyman","year":"2017","unstructured":"Lyman GH, Somerfield MR, Bosserman LD, Perkins CL, Weaver DL, Giuliano AE. Sentinel lymph node biopsy for patients with early-stage breast cancer: american society of clinical oncology clinical practice guideline update. J Clin Oncol. 2017;35(5):561\u20134. https:\/\/doi.org\/10.1200\/JCO.2016.71.0947.","journal-title":"J Clin Oncol."},{"issue":"9","key":"10441_CR25","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1245\/s10434-018-6519-1","volume":"25","author":"M Moossdorff","year":"2018","unstructured":"Moossdorff M, Nakhlis F, Hu J, et al. The potential impact of AMAROS on the management of the axilla in patients with clinical T1\u20132N0 breast cancer undergoing primary total mastectomy. Ann Surg Oncol. 2018;25(9):2612\u20139. https:\/\/doi.org\/10.1245\/s10434-018-6519-1.","journal-title":"Ann Surg Oncol."},{"issue":"12","key":"10441_CR26","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.1245\/s10434-018-6525-3","volume":"25","author":"S Grossmith","year":"2018","unstructured":"Grossmith S, Nguyen A, Hu J, et al. Multidisciplinary management of the axilla in patients with cT1\u2013T2 N0 breast cancer undergoing primary mastectomy: results from a prospective single-institution series. Ann Surg Oncol. 2018;25(12):3527\u201334. https:\/\/doi.org\/10.1245\/s10434-018-6525-3.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"10441_CR27","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s10549-019-05243-7","volume":"176","author":"A Weiss","year":"2019","unstructured":"Weiss A, Lin H, Babiera GV, et al. Evolution in practice patterns of axillary management following mastectomy in patients with 1\u20132 positive sentinel nodes. Breast Cancer Res Treat. 2019;176(2):435\u201344. https:\/\/doi.org\/10.1007\/s10549-019-05243-7.","journal-title":"Breast Cancer Res Treat."},{"issue":"1","key":"10441_CR28","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10549-019-05520-5","volume":"180","author":"AB Tadros","year":"2020","unstructured":"Tadros AB, Moo TA, Stempel M, Zabor EC, Khan AJ, Morrow M. Axillary management for young women with breast cancer varies between patients electing breast-conservation therapy or mastectomy. Breast Cancer Res Treat. 2020;180(1):197\u2013205. https:\/\/doi.org\/10.1007\/s10549-019-05520-5.","journal-title":"Breast Cancer Res Treat."},{"issue":"5","key":"10441_CR29","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1245\/s10434-021-09674-9","volume":"28","author":"MLG Vane","year":"2021","unstructured":"Vane MLG, Hunter-Squires J, Kim S, Smidt ML, Giuliano AE. Women could avoid axillary lymph node dissection by choosing breast-conserving therapy instead of mastectomy. Ann Surg Oncol. 2021;28(5):2522\u20138. https:\/\/doi.org\/10.1245\/s10434-021-09674-9.","journal-title":"Ann Surg Oncol."},{"key":"10441_CR30","doi-asserted-by":"publisher","unstructured":"Poortmans PM, Weltens C, Fortpied C, et al. Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922\/10925): 15-year results of a randomised, phase 3 trial [published correction appears in Lancet Oncol. 2021 Jan;22(1):e5].\u00a0Lancet Oncol. 2020;21(12):1602\u20131610. https:\/\/doi.org\/10.1016\/S1470-2045(20)30472-1","DOI":"10.1016\/S1470-2045(20)30472-1"},{"key":"10441_CR31","unstructured":"AJCC Cancer Staging Manual, Eighth Edition\u00a9 The American College of Surgeons (ACS). Updated 13 Mar 2018. https:\/\/cancerstaging.org\/-tools\/desk\/Documents\/AJCC%208th%20Edition%20Breast%20Cancer%20Staging%20System.pdf. Accessed 4 May 2021"},{"issue":"5","key":"10441_CR32","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1245\/s10434-019-08104-1","volume":"27","author":"AV Barrio","year":"2020","unstructured":"Barrio AV, Downs-Canner S, Edelweiss M, et al. Microscopic extracapsular extension in sentinel lymph nodes does not mandate axillary dissection in z0011-eligible patients. Ann Surg Oncol. 2020;27(5):1617\u201324. https:\/\/doi.org\/10.1245\/s10434-019-08104-1.","journal-title":"Ann Surg Oncol."},{"issue":"20","key":"10441_CR33","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1200\/JCO.19.02850","volume":"38","author":"DA Shumway","year":"2020","unstructured":"Shumway DA, Momoh AO, Sabel MS, Jagsi R. Integration of breast reconstruction and postmastectomy radiotherapy. J Clin Oncol. 2020;38(20):2329\u201340. https:\/\/doi.org\/10.1200\/JCO.19.02850.","journal-title":"J Clin Oncol."},{"key":"10441_CR34","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-021-09931-x","author":"CS Cortina","year":"2021","unstructured":"Cortina CS, Kong AL. Comment on \u201cwomen could avoid axillary lymph node dissection by choosing breast-conserving therapy instead of mastectomy.\u201d Ann Surg Oncol. 2021. https:\/\/doi.org\/10.1245\/s10434-021-09931-x.","journal-title":"Ann Surg Oncol"},{"key":"10441_CR35","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-021-09934-8","author":"AE Giuliano","year":"2021","unstructured":"Giuliano AE, Vane M. Reply to comment on: \u201cwomen could avoid axillary lymph node dissection by choosing breast-conserving therapy instead of mastectomy.\u201d Ann Surg Oncol. 2021. https:\/\/doi.org\/10.1245\/s10434-021-09934-8.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10441_CR36","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.ijrobp.2019.06.2509","volume":"105","author":"JP Gross","year":"2019","unstructured":"Gross JP, Lynch CM, Flores AM, et al. Determining the organ at risk for lymphedema after regional nodal irradiation in breast cancer. Int J Radiat Oncol Biol Phys. 2019;105(3):649\u201358. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.06.2509.","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"1","key":"10441_CR37","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ijrobp.2018.03.046","volume":"102","author":"JP Gross","year":"2018","unstructured":"Gross JP, Sachdev S, Helenowski IB, et al. Radiation therapy field design and lymphedema risk after regional nodal irradiation for breast cancer. Int J Radiat Oncol Biol Phys. 2018;102(1):71\u20138. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.03.046.","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"6","key":"10441_CR38","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/tbj.12495","volume":"21","author":"AD Currey","year":"2015","unstructured":"Currey AD, Bergom C, Kelly TR, Wilson JF. Reducing the human burden of breast cancer: advanced radiation therapy yields improved treatment outcomes. Breast J. 2015;21(6):610\u201320. https:\/\/doi.org\/10.1111\/tbj.12495.","journal-title":"Breast J."},{"key":"10441_CR39","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.breast.2016.06.016","volume":"30","author":"C Tinterri","year":"2016","unstructured":"Tinterri C, Canavese G, Bruzzi P, Dozin B. SINODAR ONE, an ongoing randomized clinical trial to assess the role of axillary surgery in breast cancer patients with one or two macrometastatic sentinel nodes. Breast. 2016;30:197\u2013200. https:\/\/doi.org\/10.1016\/j.breast.2016.06.016.","journal-title":"Breast."},{"issue":"1","key":"10441_CR40","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/s12885-017-3361-y","volume":"17","author":"J de Boniface","year":"2017","unstructured":"de Boniface J, Frisell J, Andersson Y, et al. Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial. BMC Cancer. 2017;17(1):379. https:\/\/doi.org\/10.1186\/s12885-017-3361-y.","journal-title":"BMC Cancer."},{"issue":"12","key":"10441_CR41","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.clon.2015.07.005","volume":"27","author":"A Goyal","year":"2015","unstructured":"Goyal A, Dodwell D. POSNOC: a randomised trial looking at axillary treatment in women with one or two sentinel nodes with macrometastases. Clin Oncol (R Coll Radiol). 2015;27(12):692\u20135. https:\/\/doi.org\/10.1016\/j.clon.2015.07.005.","journal-title":"Clin Oncol (R Coll Radiol)."},{"issue":"5","key":"10441_CR42","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1007\/s11764-019-00799-1","volume":"13","author":"LT Dean","year":"2019","unstructured":"Dean LT, Ransome Y, Frasso-Jaramillo L, et al. Drivers of cost differences between US breast cancer survivors with or without lymphedema. J Cancer Surviv. 2019;13(5):804\u201314. https:\/\/doi.org\/10.1007\/s11764-019-00799-1.","journal-title":"J Cancer Surviv."},{"issue":"2","key":"10441_CR43","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1001\/jamaoncol.2017.3625","volume":"4","author":"M Morrow","year":"2018","unstructured":"Morrow M. Management of the Node-Positive Axilla in Breast Cancer in 2017: Selecting the Right Option. JAMA Oncol. 2018;4(2):250\u20131.","journal-title":"JAMA Oncol."},{"issue":"11","key":"10441_CR44","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1001\/jamaoncol.2018.1939","volume":"4","author":"SH Javid","year":"2018","unstructured":"Javid SH, Anderson BO. Delayed adoption of evidence-based breast cancer surgical practices: history repeats itself. JAMA Oncol. 2018;4(11):1517\u20138. https:\/\/doi.org\/10.1001\/jamaoncol.2018.1939.","journal-title":"JAMA Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-10441-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-021-10441-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-10441-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T22:03:28Z","timestamp":1630793008000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-021-10441-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,10]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["10441"],"URL":"https:\/\/doi.org\/10.1245\/s10434-021-10441-z","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,10]]},"assertion":[{"value":"8 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Chandler S. Cortina, Carmen Bergom, Morgan Ashley Craft, British Fields, Ruta\u00a0Brazauskas, Adam Currey, and Amanda L. Kong have no relevant disclosures to report.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Dislcosure"}}]}}